Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADEPT: Adjuvant therapy de-escalation in p16+ oropharynx cancer
NCT01687413Phase 3Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Jan 2013
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cisplatin in oropharyngeal squamous cell carcinoma (OPSCC), sponsored by Washington University School of Medicine. Started Jan 2013; status: terminated.
02
Drugs
cisplatin
03
Conditions
oropharyngeal squamous cell carcinoma (OPSCC)
Beyond the preview
Go deeper on NCT01687413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01687413.